Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.44    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.445
Spread: 0.015 (0.617%)
Market Cap: $8.05b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Annoucement

2 Jul 2014 09:13

RNS Number : 1987L
Commercial Intnl Bank (Egypt) SAE
02 July 2014
 



Commercial International Bank (Egypt) S.A.E.

Publication of Prospectus and Expected Listing and Admission of up to 500,000,000 Additional Global Depositary Receipts

The following prospectus (the "Prospectus") has been approved by the UK Listing Authority and is available for viewing:

Prospectus dated 1 July 2014

Commercial International Bank (Egypt) S.A.E. - Prospectus in relation to the listing and admission to the Official List and to trading on the London Stock Exchange of up to 500,000,000 Additional Global Depositary Receipts

For details of how the full document can be viewed, please consult the following URL:

http://www.rns-pdf.londonstockexchange.com/rns/1987L_-2014-7-2.pdf
 

The Prospectus is available for viewing at the registered office of Commercial International Bank (Egypt) S.A.E. ("CIB") (Nile Tower Building, 21/23 Charles de Gaulle Street, Giza, P.O. Box 2430, Cairo, Egypt).

In addition, a copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.

The listing and admission to the Official List and to trading on the main market of the London Stock Exchange of up to 500,000,000 Additional Global Depositary Receipts is expected to occur on 4 July 2014 ("Admission"). The Admission will bring the total number of Global Depositary Receipts listed by CIB to up to 680,000,000.

No Global Depositary Receipts have been or are being offered or marketed to the public in the United Kingdom or elsewhere in connection with the Admission.

DISCLAIMER - INTENDED ADDRESSEES

The distribution of this announcement may be restricted by law in certain jurisdictions. Persons into whose possession this document comes are required to inform themselves about and to observe any such restrictions.

This announcement does not, and shall not, in any circumstances constitute a public offering of shares, or Global Depositary Receipts representing such shares, in CIB nor an invitation to the public in connection with any offer. No action has been or will be taken in any country or jurisdiction that would permit a public offering of securities, or the possession or distribution of this announcement or any other offering or publicity material relating to the securities in any country or jurisdiction where action for that purpose is required. The acquisition of securities may be subject to specific legal or regulatory restrictions in certain jurisdictions. CIB takes no responsibility for any violation of any such restrictions by any person.

This announcement is not an offer for sale of securities in the United States. Securities may not be sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended.

This announcement is an advertisement and is not a prospectus for the purposes of the Prospectus Directive. In any EEA Member State that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive. The expression "Prospectus Directive" means Directive 2003/71/EC (and any amendments thereto, including Directive 2010/73/EU, to the extent implemented in any relevant Member State) and includes any relevant implementing measure in the relevant Member State.

This announcement is only being distributed to and is only directed at (i) persons who are outside the United Kingdom; (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"); or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "relevant persons"). Any person who is not a relevant person should not act or rely on this document or any of its contents.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRTMPTMBBMMTI
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.